Related Experiment Video
Updated: Jun 23, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
[Respiratory infections, Down's syndrome and congenital heart disease: the CIVIC 21 study]
C Medrano López1, L García-Guereta Silva, J Lirio Casero
1Cardiología Pediátrica, Hospital General Universitario Gregorio Marañón, Madrid, España. consmelu@yahoo.es
Insights
Children with Down syndrome and respiratory infections, especially respiratory syncytial virus, face higher hospitalisation rates. This risk is amplified in those with non-significant congenital heart disease and low immunoprophylaxis rates.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Acute respiratory tract infections pose a significant health risk to young children.
- Congenital heart disease (CHD) and Down syndrome (DS) are known risk factors for severe respiratory infections.
Purpose of the Study:
- To compare hospitalization rates for acute respiratory tract infections (ARTI) in children under 24 months.
- To assess the impact of Down syndrome and congenital heart disease on ARTI hospitalization.
Main Methods:
- An epidemiological, multicenter, observational, prospective study involving 1085 children (October 2006 - April 2007).
- Patients were categorized based on the presence and severity of Down syndrome and congenital heart disease.
- Hospitalization rates for respiratory infections were compared across these groups.
Main Results:
- Overall, 13.1% of children were hospitalized for respiratory infections.
- Hospitalization rates were higher in children with Down syndrome (19.1%) compared to those without (11%).
- Children with Down syndrome and non-significant CHD had the highest admission rate (15.8%) for respiratory syncytial virus (RSV).
Conclusions:
- Children with Down syndrome exhibit increased hospitalization rates for respiratory infections, particularly RSV.
- The risk is most pronounced in Down syndrome patients with non-significant CHD and low RSV immunoprophylaxis.
- No significant differences were observed in hospital stay duration or severity of illness.
Introduction:
We compare hospitalisation rates for acute respiratory tract infection in children younger than 24 months with significant congenital heart disease without Down's syndrome with those with Down's syndrome with or without congenital heart disease.
Material And Methods:
This was an epidemiological, multicentre (53 Spanish hospitals), observational and prospective study, from October 2006 to April 2007. A total of 1085 patients were followed-up, of which 806 did not have Down's syndrome and 279 with Down's syndrome: 135 with significant, 38 with non significant and 105 without congenital heart disease.
Results:
A total of 147 patients (13.1%; 95% CI, 11.2-15.2%) required hospitalisation due to respiratory infection. Rates in patients without and with Down's syndrome were 11% vs 19.1%. In the Down's group, 26.3% had no significant, a 23% had significant and 11.4% had no congenital heart disease. The main diagnosis was bronchiolitis (59.4%). An infectious agent was found in 36.2% cases. The specific admission rate due to respiratory syncytial virus was 4.4%, with differences in children without vs with Down's syndrome (3.2% vs 7.8%). In the Down's patients we found rates of 15.8%, 9.3% and 3% in the non-significant, significant and no congenital heart disease. Immunoprophylaxis against respiratory syncytial virus rates were 83.4% vs 39.9% in no Down's versus Down's syndrome patients. No differences were found in hospital stay or the severity.
Conclusions:
Hospital admission rates due to respiratory infection, and specifically respiratory syncytial virus, were higher in the Down's patients, particularly in the group with no significant congenital heart disease and low immunoprophylaxis against respiratory syncytial virus.
More Related Videos
08:28Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Respiratory Syncytial Virus Disease
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Meiosis I
Other Pulmonary Disorders
Microbiota of the Respiratory Tract
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: